Kreg Therapeutics

Kreg Therapeutics is a specialty hospital bed provider focused on enhancing patient outcomes and reducing hospital stays for complex patients, particularly in intensive care units (ICUs). The company designs and manufactures its beds in the USA, ensuring high quality and a robust service network. Their strategically located service centers enable timely delivery, setup, and training for clinical staff. The flagship product, the Catalyst®, facilitates the mobilization of complex ICU patients, including those who are often unresponsive or unstable. This bed supports verticalization and in-bed mobilization, aiding recovery in various medical conditions, including those requiring life-support devices. Kreg Therapeutics serves a wide range of clients, including many of the top trauma centers in the United States, and has positively impacted over 350,000 patients nationwide. The company operates from Melrose Park, Illinois, and is led by a team with extensive healthcare and investment experience.

• Employees130
• Annual Revenue$18150000